Inari Medical, Inc. Common Stock
NARI
NARI was delisted on the 18th of February, 2025.
250 hedge funds and large institutions have $3B invested in Inari Medical, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 118 increasing their positions, 61 reducing their positions, and 45 closing their positions.
342% more call options, than puts
Call options by funds: $27.4M | Put options by funds: $6.2M
93% more repeat investments, than reductions
Existing positions increased: 118 | Existing positions reduced: 61
2% less capital invested
Capital invested by funds: $3.06B → $3B (-$59M)
2% less funds holding
Funds holding: 256 → 250 (-6)
13% less first-time investments, than exits
New positions opened: 39 | Existing positions closed: 45
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$46.3M |
| 2 |
JP Morgan Chase
New York
|
+$45.8M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$30.7M |
| 4 |
FAM
Fred Alger Management
New York
|
+$28.6M |
| 5 |
Millennium Management
New York
|
+$25.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$127M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$38.4M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$31.8M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$24.1M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$20.7M |
NARI Hedge Fund Activity: Q2 2023 in Review
250 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Inari Medical, Inc. Common Stock (NARI) for Q2 2023, worth a combined $3B — down 1.9% from $3.06B a quarter earlier.
Sellers outnumbered buyers: 45 funds closed out of NARI and 39 opened new positions — a net loss of 6 holders — while 61 trimmed existing stakes and 118 added.
The largest buyer was BlackRock, adding an estimated $46.3M. The largest seller was Point72 Asset Management, cutting an estimated $127M.
- 250 institutional investors held Inari Medical, Inc. Common Stock (NARI) as of Q2 2023, down from 256 in Q1 2023.
- Funds reported $3B of Inari Medical, Inc. Common Stock stock for Q2 2023, down 1.9% quarter-over-quarter.
- 39 funds opened new Inari Medical, Inc. Common Stock positions in Q2 2023 and 45 closed out, a net change of -6 holders.
- The largest Inari Medical, Inc. Common Stock buyer in Q2 2023 was BlackRock, an estimated $46.3M added.
- The largest Inari Medical, Inc. Common Stock seller in Q2 2023 was Point72 Asset Management, an estimated $127M sold.
Based on aggregated 13F filings for Q2 2023.